All Stories

  1. Author Correction: Pan-cancer analysis of whole genomes
  2. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  3. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  4. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  5. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  6. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  7. Author Correction: Inferring structural variant cancer cell fraction
  8. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  9. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  10. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  11. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  12. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  13. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  14. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  15. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  16. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  17. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  18. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  19. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  20. Intraparenchymal breast leiomyoma and atypical leiomyoma
  21. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  22. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  23. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  24. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  25. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  26. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  27. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  28. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  29. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  30. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  31. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  32. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  33. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  34. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  35. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  36. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  37. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  38. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  39. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  40. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  41. Sex differences in oncogenic mutational processes
  42. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  43. Pan-cancer analysis of whole genomes
  44. Genomic subtyping of liver cancers with prognostic application
  45. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  46. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  47. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  48. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  49. Forward and reverse mutations in stages of cancer development
  50. Forward-reverse mutation cycles between stages of cancer development
  51. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  52. Tripartite genome of all species
  53. Feature co-localization landscape of the human genome
  54. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  55. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  56. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later